Statins May Be Safe for Some Lymphoma Patients


Patients with follicular lymphoma may be able to safely use statins, according to a new study published in the American Journal of Hematology.

Rituxmab, a drug often prescribed for follicular non-Hodgkin's lymphoma, has had a negative association with statins in laboratory experiments, according to Lymphoma News Today. However, the new research suggests the two drugs do not worsen a patient's condition.

The research was conducted at Claude Bernard University Lyon in France, where 1,135 patients were studied for adverse effects and overall survival while taking statins, rituxmab, or both of these medications.

Statins and cancer

A large body of research suggests that statins are linked to an increased risk of various types of cancer or worsening of tumors, especially in patients with breast or prostate cancer.

However, the current study found no differences in survival rates or adverse effects between patients taking just rituxmab or both rituxmab and statins.

"The rates of overall and specific cardiovascular adverse events between the 2 groups of patients were comparable both during induction and maintenance," the study authors wrote.

Source: Lymphoma News Today, Healthline

LymphomaInfo Social